Emmaus Life Sciences, Inc.

Emmaus Life Sciences, Inc.verified

EMMA

Price:

$0.03

Market Cap:

$1.92M

Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. Emmaus ...[Read more]

Industry

Biotechnology

IPO Date

2000-05-09

Stock Exchange

PNK

Ticker

EMMA

The PE Ratio as of November 2024 (TTM) for Emmaus Life Sciences, Inc. (EMMA) is -0.43

According to Emmaus Life Sciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.43. This represents a change of -106.84% compared to the average of 6.29 of the last 4 quarters.

Emmaus Life Sciences, Inc. (EMMA) Historical PE Ratio (quarterly & annually)

How has EMMA PE Ratio performed in the past?

The mean historical PE Ratio of Emmaus Life Sciences, Inc. over the last ten years is 2.19. The current -0.43 PE Ratio has changed -2063.88% with respect to the historical average. Over the past ten years (40 quarters), EMMA's PE Ratio was at its highest in in the September 2023 quarter at 25.02. The PE Ratio was at its lowest in in the December 2020 quarter at -28.91.

Quarterly (TTM)
Annual

Average

2.19

Median

-1.47

Minimum

-8.39

Maximum

44.42

Emmaus Life Sciences, Inc. (EMMA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Emmaus Life Sciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 302.57%

Maximum Annual PE Ratio = 44.42

Minimum Annual Increase = -3026.12%

Minimum Annual PE Ratio = -8.39

Quarterly (TTM)
Annual
YearPE RatioChange
2023-1.4218.21%
2022-1.20-76.65%
2021-5.16-111.61%
202044.42-3026.12%
2019-1.5276.25%
2018-0.86-42.93%
2017-1.51132.81%
2016-0.65-64.14%
2015-1.81-78.46%
2014-8.39302.57%

Emmaus Life Sciences, Inc. (EMMA) Average PE Ratio

How has EMMA PE Ratio performed in the past?

The current PE Ratio of Emmaus Life Sciences, Inc. (EMMA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-2.60

5-year avg

7.02

10-year avg

2.19

Emmaus Life Sciences, Inc. (EMMA) PE Ratio vs. Peers

How is EMMA’s PE Ratio compared to its peers?

Emmaus Life Sciences, Inc.’s PE Ratio is greater than NRx Pharmaceuticals, Inc. (-0.56), less than Kaleido Biosciences, Inc. (0), less than Applied Molecular Transport Inc. (-0.14), less than Scopus BioPharma Inc. (-0.00), less than Cell Source, Inc. (0), greater than Adhera Therapeutics, Inc. (-4.87), less than PolarityTE, Inc. (-0.00), less than ZIVO Bioscience, Inc. (0.14), greater than Anebulo Pharmaceuticals, Inc. (-4.57), greater than Adagene Inc. (-5.13), greater than Acrivon Therapeutics, Inc. Common Stock (-3.64), greater than AnaptysBio, Inc. (-4.49), greater than Mineralys Therapeutics, Inc. (-3.72), greater than null (-5.79),

Build a custom stock screener for Emmaus Life Sciences, Inc. (EMMA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Emmaus Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Emmaus Life Sciences, Inc. (EMMA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Emmaus Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Emmaus Life Sciences, Inc.'s PE Ratio?

How is the PE Ratio calculated for Emmaus Life Sciences, Inc. (EMMA)?

What is the highest PE Ratio for Emmaus Life Sciences, Inc. (EMMA)?

What is the 3-year average PE Ratio for Emmaus Life Sciences, Inc. (EMMA)?

What is the 5-year average PE Ratio for Emmaus Life Sciences, Inc. (EMMA)?

How does the current PE Ratio for Emmaus Life Sciences, Inc. (EMMA) compare to its historical average?